PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
18.04%
Net income growth under 50% of ORCL's 53.43%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-1.49%
Negative yoy D&A while ORCL is 12.75%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-14.29%
Both reduce yoy usage, with ORCL at -69900.00%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
-42.86%
Negative yoy inventory while ORCL is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
14.29%
Some yoy usage while ORCL is negative at -69900.00%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
No Data
No Data available this quarter, please select a different quarter.
14.10%
Some CFO growth while ORCL is negative at -36.44%. John Neff would note a short-term liquidity lead over the competitor.
-53.73%
Both yoy lines negative, with ORCL at -158.47%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-50.80%
Negative yoy purchasing while ORCL stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
No Data
No Data available this quarter, please select a different quarter.
-57.14%
Both yoy lines negative, with ORCL at -806.64%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-51.81%
Both yoy lines negative, with ORCL at -1102.98%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-18.33%
Negative yoy issuance while ORCL is 492.31%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-31.40%
Both yoy lines negative, with ORCL at -37.93%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.